DGX
Quest DiagnosticsCNYSE / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
The bullish case is that Quest's Q1 2026 print showed broad operating strength: 9.2% revenue growth, 10.9% requisition volume growth, 13.1% adjusted EPS growth, and a full-year guide raise. If that volume cadence persists, the stock can still grind higher from the $196.31 anchor despite the immediate post-print reaction.
Posture
Mixed
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-07-23 · BMO.
What can break
Advanced Diagnostics and consumer-channel growth may normalize after a strong quarter
Momentum
38
Value
62
Sentiment
52
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $205.00 · Bull $225.00 · Bear $182.00
Earnings
2026-07-23 · BMO
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-21 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $226.60
Why
Momentum38 · Δ7d -12.9
Value62 · Δ7d +0.0
Sentiment52 · Δ7d -4.7
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
38
26% active weight
Current posture
7d trendFlat
Δ7d
-12.9
Δ21d
-16.4
Value
62
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.6
Sentiment
52
34% active weight
Current posture
7d trendSoftening
Δ7d
-4.7
Δ21d
-2.1
Why this grade
Composite grade C. Momentum 37.9 / Value 61.6 / Sentiment 51.8
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$23.32B
Beta
0.66
Shares Out
110.7M
P/E (TTM)
20.5
P/S (TTM)
1.78
P/FCF (TTM)
18.45
Rev YoY
+9.2%
EPS YoY
+15.6%
Gross Margin
+31.9%
Op Margin
+14.1%
Net Debt
$6.17B
Current Ratio
1.18
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology